<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36036059</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model.</ArticleTitle><Pagination><StartPage>2248</StartPage><EndPage>2263</EndPage><MedlinePgn>2248-2263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2119166</ELocationID><Abstract><AbstractText>CVA6 is one of Enteroviruses causing worldwide epidemics of HFMD with neurological and systemic complications. A suitable animal model is necessary for studying the pathogenesis of CVA6 and evaluating antiviral and vaccine efficacy. In this study, we generated a mouse-adapted CVA6 strain that successfully infected 10-day-old ICR mice via oral route. All infected mice were paralyzed and died within 11&#x2005;dpi. Analysis of pathological changes and virus loads in fourteen tissues showed that CVA6 triggered systematic damage similar to i.p. inoculation route. Unlike i.p. route, we detected oral and gastrointestinal lesions with the presence of viral antigens. Both specific anti-CVA6 serum and inactivated vaccines successfully generated immune protection in mice. Meanwhile, we also established a successful infection of CVA6 via i.p. and i.m. route in 10-day-old mice. After infection, mice developed remarkably neurological signs and systemic manifestations such as emaciation, polypnea, quadriplegia, depilation and even death. Through i.p. inoculation, pathological examination showed brain and spinal cord damage caused by the virus infection with neuronal reduction, apoptosis, astrocyte activation, and recruitment of neutrophils and monocytes. Following neurological manifestation, the CVA6 infection became systemic, and high viral loads were detected in multiple organs along with morphological changes and inflammation. Moreover, analysis of spleen cells by FACS indicated that CVA6 led to immune system activation, which further contributed to systemic inflammation. Taken together, our novel murine model of CVA6 provides a useful tool for studying the pathogenesis and evaluating antiviral and vaccine efficacy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Key Laboratory of Molecular Medicine, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Tiantian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Ling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7854-4652</Identifier><AffiliationInfo><Affiliation>School of Public Health, Xinxiang Medical University, Xinxiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Wangquan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Peiyu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Ruonan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shuaiyin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yuefei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Guangcai</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Key Laboratory of Molecular Medicine, Zhengzhou University, Zhengzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A6</Keyword><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">murine model</Keyword><Keyword MajorTopicYN="N">neurotropism</Keyword><Keyword MajorTopicYN="N">oral infection</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36036059</ArticleId><ArticleId IdType="pmc">PMC9518251</ArticleId><ArticleId IdType="doi">10.1080/22221751.2022.2119166</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. . Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010 Nov;10(11):778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, et al. . Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10(2):360&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. . Hand, foot, and mouth disease in China, 2008&#x2013;2012: an epidemiological study. Lancet Infect Dis. 2014 Apr;14(4):308&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Maimaiti H, Zhou L, et al. . Changing serotypes of hand, foot and mouth disease in Shanghai, 2017-2019. Gut Pathog. 2022 Mar 21;14(1):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935267</ArticleId><ArticleId IdType="pubmed">35313977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E, Nguyen D, Celma C, et al. . Seroprevalence and virologic surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006&#x2013;2017. Emerg Infect Dis. 2021 Sep;27(9):2261&#x2013;2268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386771</ArticleId><ArticleId IdType="pubmed">34423767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M, Tarrago D, Munoz-Almagro C, et al. . Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect. 2014 Mar;20(3):O150&#x2013;O156.</Citation><ArticleIdList><ArticleId IdType="pubmed">24033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M, Makino T, Hanaoka N, et al. . Clinical manifestations of coxsackievirus A6 infection associated with a major outbreak of hand, foot, and mouth disease in Japan. Jpn J Infect Dis. 2013;66(3):260&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">23698493</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Cohen R, Bisseux M, et al. . A large-scale outbreak of hand, foot and mouth disease, France, as at 28 September 2021. Euro Surveill. 2021 Oct;26:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8555367</ArticleId><ArticleId IdType="pubmed">34713796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalkrishna V, Patil PR, Patil GP, et al. . Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol. 2012 Mar;61(Pt 3):420&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">22052995</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Xu S, Zhang Y, et al. . Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect. 2014 Sep;69(3):303&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">24704297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim CT, Jiang L, Ma S, et al. . Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state. Epidemiol Infect. 2016 Apr;144(5):1028&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">26374168</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease C, Prevention . Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 &#x2013; Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep. 2012 Mar 30;61(12):213&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">22456122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca MC, Sarmiento L, Resik S, et al. . Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011&#x2013;2013. Arch Virol. 2014 Sep;159(9):2451&#x2013;2455.</Citation><ArticleIdList><ArticleId IdType="pubmed">24719197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao TS, Du J, Sun DP, et al. . A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications. Rev Med Virol. 2020 Mar;30(2):e2087.</Citation><ArticleIdList><ArticleId IdType="pubmed">31811676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Fort MK, Downing C, Doan HQ, et al. . Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol. 2014 Aug;60(4):381&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">24932735</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimbao J, Rodrigo P, Alberto MJ, et al. . Onychomadesis outbreak linked to hand, foot, and mouth disease, Spain, July 2008. Euro Surveill. 2010 Sep 16;15:37.</Citation><ArticleIdList><ArticleId IdType="pubmed">20929644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao CD, Yergolkar P, Shankarappa KS.. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007&#x2013;2009. Emerg Infect Dis. 2012 Nov;18(11):1833&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559176</ArticleId><ArticleId IdType="pubmed">23092622</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, Klemola P, Kaijalainen S, et al. . Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010 May;48(1):49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">20189452</ArticleId></ArticleIdList></Reference><Reference><Citation>Logotheti M, Pogka V, Horefti E, et al. . Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007. J Clin Virol. 2009 Nov;46(3):270&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">19699142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Zhang Y, Lin H, et al. . A 10-day-old murine model of coxsackievirus A6 infection for the evaluation of vaccines and antiviral drugs. Front Immunol. 2021;12:665197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155526</ArticleId><ArticleId IdType="pubmed">34054834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W, Qin L, Tao L, et al. . Neonatal murine model of coxsackievirus A2 infection for the evaluation of antiviral therapeutics and vaccination. Front Microbiol. 2021;12:658093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192712</ArticleId><ArticleId IdType="pubmed">34122374</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CX, Zhang B, Feng Y, et al. . Establishment and characterization of an oral gerbil model for a non-mouse-adapted enterovirus 71 strain. Virus Res. 2018 Aug 15;255:117&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">30030018</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CC, Liou AT, Chang YS, et al. . Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J Virol. 2014 Nov;88(21):12485&#x2013;12499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Hwang CS, Yang WS, et al. . Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques. PLoS One. 2014;9(9):e106756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157806</ArticleId><ArticleId IdType="pubmed">25197967</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JP, Liao Y, Zhang Y, et al. . Experimental infection of tree shrews (Tupaia belangeri) with Coxsackie virus A16. Dongwuxue Yanjiu. 2014 Nov 18;35(6):485&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4790277</ArticleId><ArticleId IdType="pubmed">25465084</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Sun T, Zhou G, et al. . Pathogenesis study of Enterovirus 71 using a novel human SCARB2 knock-in mouse model. mSphere. 2021 Mar 10;6:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546711</ArticleId><ArticleId IdType="pubmed">33692197</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Mao Q, Li S, et al. . A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6. Antiviral Res. 2016 Oct;134:50&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Dong Z, Wei Q, et al. . A neonatal murine model of Coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy. J Virol. 2017 May 1;91:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391469</ArticleId><ArticleId IdType="pubmed">28250116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H.. A simple method of estimating fifty per cent endpoints12. Am J Epidemiol. 1938;27(3):493&#x2013;497.</Citation></Reference><Reference><Citation>Ji W, Zhu P, Liang R, et al. . Coxsackievirus A2 leads to heart injury in a neonatal mouse model. Viruses. 2021 Aug 11;13:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8402683</ArticleId><ArticleId IdType="pubmed">34452454</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-de-Puig I, Miro-Mur F, Ferrer-Ferrer M, et al. . Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015 Feb;129(2):239&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">25548073</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubruck P, Colbath AC, Liu Y, et al. . Flow cytometry analysis of immune cell subsets within the murine spleen, bone marrow, lymph nodes and synovial tissue in an osteoarthritis model. J Vis Exp. 2020 Apr 24;e61008.</Citation><ArticleIdList><ArticleId IdType="pubmed">32420987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai Y, Zhang W, Wu J, et al. . Molecular epidemiology and clinical features of enteroviruses-associated hand, foot, and mouth disease and herpangina outbreak in Zunyi, China, 2019. Front Med (Lausanne). 2021;8:656699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8109248</ArticleId><ArticleId IdType="pubmed">33981716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang Z, Rao Q, et al. . The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China. Emerg Microbes Infect. 2021 Dec;10(1):619&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="pubmed">33682641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Iizuka S, Enomoto M, et al. . Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis. 2012 Feb;18(2):337&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3310456</ArticleId><ArticleId IdType="pubmed">22304983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei SH, Huang YP, Liu MC, et al. . An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis. 2011 Dec 14;11:346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297538</ArticleId><ArticleId IdType="pubmed">22168544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan LNT, Khanh TH, Hong NTT, et al. . Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015&#x2013;2018. PLoS Negl Trop Dis. 2020 Aug;14(8):e0008544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7451980</ArticleId><ArticleId IdType="pubmed">32804980</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa IP, Giamberardino HI, Raboni SM, et al. . Simultaneous enterovirus EV-D68 and CVA6 infections causing acute respiratory distress syndrome and hand, foot and mouth disease. Virol J. 2021 Apr 30;18(1):88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8085469</ArticleId><ArticleId IdType="pubmed">33931064</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhang M, Feng C, et al. . Characterization of Coxsackievirus A6 strains isolated from children with hand, foot, and mouth disease. Front Cell Infect Microbiol. 2021;11:700191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418080</ArticleId><ArticleId IdType="pubmed">34490141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G, Carr MJ, Kobayashi M, et al. . Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world. Int J Mol Sci. 2019 Oct 20;20:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Li D, Sun T, et al. . Pathological features of Enterovirus 71-associated brain and lung damage in mice based on quantitative proteomic analysis. Front Microbiol. 2021;12:663019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249819</ArticleId><ArticleId IdType="pubmed">34220748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Liu CC.. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol. 2012: 876241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="pubmed">22956971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YS, Yang ZN, Xu F, et al. . Global gene expression analysis of the brainstem in EV71- and CVA16-infected gerbils. Viruses. 2019 Dec 30;12:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7019476</ArticleId><ArticleId IdType="pubmed">31906004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Huang Z, Huang M, et al. . Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflamm. 2020; 9273241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7013319</ArticleId><ArticleId IdType="pubmed">32089650</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing J, Liu D, Shen S, et al. . Pathologic studies of fatal encephalomyelitis in children caused by Enterovirus 71. Am J Clin Pathol. 2016 Jul;146(1):95&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">27357294</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, et al. . A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012 Feb;86(4):2121&#x2013;2131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian SS, Wei ZN, Jin WP, et al. . Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model. Emerg Microbes Infect. 2021 Dec;10(1):763&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8079124</ArticleId><ArticleId IdType="pubmed">33739899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R, Racaniello VR.. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis. 1992 Oct;166(4):747&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">1326581</ArticleId></ArticleIdList></Reference><Reference><Citation>Douche-Aourik F, Berlier W, Feasson L, et al. . Detection of enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or fibromyalgia and healthy subjects. J Med Virol. 2003 Dec;71(4):540&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">14556267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Badmanathan M, Devi S, et al. . Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol. 2008 Jun;67(6):532&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JG, Qu D, Li Y, et al. . Acute kidney injury in critically ill children infected with influenza A virus (H1N1) and enterovirus 71. Zhonghua Er Ke Za Zhi. 2011 Nov;49(11):839&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">22336307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TC, Wang YF, Lee YP, et al. . Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol. 2007 Oct;81(19):10310&#x2013;10315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045469</ArticleId><ArticleId IdType="pubmed">17626076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Chang KC, Kao CM, et al. . Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol. 2009 Jul;83(13):6477&#x2013;6483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Cai C, Feng J, et al. . Peripheral T lymphocyte subset imbalances in children with enterovirus 71-induced hand, foot and mouth disease. Virus Res. 2014 Feb 13;180:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24316007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Hsia SH, et al. . The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis. 2002 May 1;34(Suppl. 2):S52&#x2013;S57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan MA, Craig ME, Lahra MM, et al. . Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology. 2003 May 27;60(10):1651&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pubmed">12771257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chow YH, Chong P, et al. . Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine. 2014 Oct 29;32(47):6177&#x2013;6182.</Citation><ArticleIdList><ArticleId IdType="pubmed">25218294</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>